MAP2K7 and thyroid cancer: Studies have also verified the crosstalk between MAPK and GLI1 in thyroid cancers; in addition, an MEK inhibitor inhibits GLI1 activation, which suggests the possibility of a non-canonical mechanism of hedgehog signaling pathway activation [15].